These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36982885)

  • 1. MiR-424/TGIF2-Mediated Pro-Fibrogenic Responses in Oral Submucous Fibrosis.
    Chou MY; Hsieh PL; Chao SC; Liao YW; Yu CC; Tsai CY
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting lncRNA H19/miR-29b/COL1A1 Axis Impedes Myofibroblast Activities of Precancerous Oral Submucous Fibrosis.
    Yu CC; Liao YW; Hsieh PL; Chang YC
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of miR-497 Attenuates Oral Submucous Fibrosis by Inhibiting Myofibroblast Transdifferentiation in Buccal Mucosal Fibroblasts.
    Huang J; Zhang H; Fan X; Guo J
    Oral Health Prev Dent; 2022 Aug; 20():339-348. PubMed ID: 35920886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-200b ameliorates myofibroblast transdifferentiation in precancerous oral submucous fibrosis through targeting ZEB2.
    Liao YW; Yu CC; Hsieh PL; Chang YC
    J Cell Mol Med; 2018 Sep; 22(9):4130-4138. PubMed ID: 29893466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA LINC00974 activates TGF-β/Smad signaling to promote oral fibrogenesis.
    Fang CY; Yu CC; Liao YW; Hsieh PL; Lu MY; Lin KC; Wu CZ; Tsai LL
    J Oral Pathol Med; 2019 Feb; 48(2):151-158. PubMed ID: 30447113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-1246 as a therapeutic target in oral submucosa fibrosis pathogenesis.
    Liu CM; Liao YW; Hsieh PL; Yu CH; Chueh PJ; Lin T; Yang PY; Yu CC; Chou MY
    J Formos Med Assoc; 2019 Jul; 118(7):1093-1098. PubMed ID: 30928188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-10b regulated by Twist maintains myofibroblasts activities in oral submucous fibrosis.
    Fang CY; Yu CC; Liao YW; Hsieh PL; Ohiro Y; Chu PM; Huang YC; Yu CH; Tsai LL
    J Formos Med Assoc; 2020 Jul; 119(7):1167-1173. PubMed ID: 32265096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arecoline enhances miR-21 to promote buccal mucosal fibroblasts activation.
    Yang HW; Yu CC; Hsieh PL; Liao YW; Chu PM; Yu CH; Fang CY
    J Formos Med Assoc; 2021 Apr; 120(4):1108-1113. PubMed ID: 33191095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depletion of miR-155 hinders the myofibroblast activities and reactive oxygen species generation in oral submucous fibrosis.
    Chou MY; Fang CY; Hsieh PL; Liao YW; Yu CC; Lee SS
    J Formos Med Assoc; 2022 Feb; 121(2):467-472. PubMed ID: 34274194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arctigenin Reduces Myofibroblast Activities in Oral Submucous Fibrosis by LINC00974 Inhibition.
    Lin CY; Hsieh PL; Liao YW; Peng CY; Yu CC; Lu MY
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30884781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrantly downregulated FENDRR by arecoline elevates ROS and myofibroblast activation via mitigating the miR-214/MFN2 axis.
    Liao YW; Yu CC; Hsieh CW; Chao SC; Hsieh PL
    Int J Biol Macromol; 2024 Apr; 264(Pt 1):130504. PubMed ID: 38442830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of miR-29c promotes the progression of oral submucous fibrosis through targeting tropomyosin-1.
    Yang PY; Ho DC; Chen SH; Hsieh PL; Liao YW; Tsai LL; Yu CC; Fang CY
    J Formos Med Assoc; 2022 Jun; 121(6):1117-1122. PubMed ID: 34696938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. XIST/let-7i/HMGA1 axis maintains myofibroblasts activities in oral submucous fibrosis.
    Yu CH; Hsieh PL; Chao SC; Chen SH; Liao YW; Yu CC
    Int J Biol Macromol; 2023 Mar; 232():123400. PubMed ID: 36702230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LINC00312/YBX1 Axis Regulates Myofibroblast Activities in Oral Submucous Fibrosis.
    Yu CH; Fang CY; Yu CC; Hsieh PL; Liao YW; Tsai LL; Chu PM
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomes Derived from Human Adipose Mesenchymal Stem Cells Inhibits Fibrosis and Treats Oral Submucous Fibrosis via the miR-181a-5p/Smad2 Axis.
    Shao Z; Xu J; Xu X; Wang X; Zhou Y; Li Y; Li K
    Tissue Eng Regen Med; 2024 Jan; 21(1):123-135. PubMed ID: 37755664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glabridin inhibits the activation of myofibroblasts in human fibrotic buccal mucosal fibroblasts through TGF-β/smad signaling.
    Lee PH; Chu PM; Hsieh PL; Yang HW; Chueh PJ; Huang YF; Liao YW; Yu CC
    Environ Toxicol; 2018 Feb; 33(2):248-255. PubMed ID: 29119715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. circMTO1/miR-30c-5p/SOCS3 axis alleviates oral submucous fibrosis through inhibiting fibroblast-myofibroblast transition.
    Bin X; Cheng JY; Deng ZY; Li B; Xu XH; Liu OS; Tang Z
    J Oral Pathol Med; 2024 Aug; 53(7):468-479. PubMed ID: 38802299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing periostin inhibits myofibroblast transdifferentiation of fibrotic buccal mucosal fibroblasts.
    Su JY; Yu CC; Peng CY; Liao YW; Hsieh PL; Yang LC; Yu CH; Chou MY
    J Formos Med Assoc; 2021 Nov; 120(11):2010-2015. PubMed ID: 33965260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-200c inhibits the arecoline-associated myofibroblastic transdifferentiation in buccal mucosal fibroblasts.
    Lu MY; Yu CC; Chen PY; Hsieh PL; Peng CY; Liao YW; Yu CH; Lin KH
    J Formos Med Assoc; 2018 Sep; 117(9):791-797. PubMed ID: 29958727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carvacrol inhibits the progression of oral submucous fibrosis via downregulation of PVT1/miR-20a-5p-mediated pyroptosis.
    Yu CC; Hsieh PL; Chao SC; Liao YW; Yu CH; Chueh PJ; Peng CY; Lee SS
    J Cell Mol Med; 2024 Sep; 28(18):e70112. PubMed ID: 39320020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.